Summary: The effect of sodium valproate (200 mg/kg body weight) on renal cells was investigated during a 10-day trial, by determining the catalytic activities of alanine aminopeptidase, γ-glutamyltransferase and alkaline phosphatase in the membrane cell brush-border of the renal proximal tubules.
Introduction
Considering the numerous metabolic effects of sodium 0 ,. ι * / j· j· ι * * \ · *· valproate (12) , especially on the metabolism of fatty Sodium valproate (sodium dipropyl acetate) is an anti-Λ . , . , , , , -•ι χ· i-t u t S -j A·* u acids, it may also conceivably disturb the integrity or epileptic which has a number of side effects, such as _ ! _ ; f " ; _ f . , , . . . .. , j.
~ , ,.,. , A . ,. function of the renal cell membrane. On the other hand, gastrointestinal discomforts, pancreatitis, body weight . f . . . . . ,
-. · " ju ι · · u ^ increased catalytic activities of some renal enzymes in gain, hyperglyemaemia and hyperglycmuria, changes of . , -, ,. , , " * , . *. \ ,ι\ τ ·* u f Λ u *· * urine (otherwise localized on the cell membrane of the coagulation, etc. (1) . In quite a number of adult patients , · , , , * , --" . /-υ Λ j · -* s r Λ-renal proximal tubules) are known to be among the earhand especially in children, the administration of sodium . *,. _ t ., y tl . . . . ° X1^V , . . , . . -... ., , ι . -est indicators of kidney cell pathologic alterations (13) . valproate is also associated with the development of r v ' acute (2, 3) or chronic hyperammonaemia (4, 5) . The Therefore, the effect of sodium valproate on rat kidney genesis of hyperammonaemia has not yet been fully ex-cells was followed by monitoring the catalytic activities plained, but two mechanisms have attracted particular of alanine aminopeptidase 1 ), alkaline phosphatase 1 ) and attention: decreased ammonium detoxification via urea γ-glutamyltransferase 1 ) in urine and isolated brush-borsynthesis in the liver (6) , and increased glutamine me-der membrane vesicles of the renal proximal tubules, tabolism and increased ammonium synthesis in the kidney (7) (8) (9) . Cases of serious renal damage, such as interstitial nephritis (10) and proximal renal tubule dysfunc-'), Enzymes: 
Materials and Methods

Material
The study was performed on male Fisher rats (n = 29) aged 1 month, mean body weight 100g. The animals had free access to chow and water throughout the study. The animals were divided into four groups: the control group (n = 6) received 1 ml saline (0.154 mol/1 NaCl) daily per os. The experimental group (n = 23) received 200 mg/kg body weight sodium valproate daily per os in the same volume. Experimental animals were sacrificed by severing the cranial spine on day 1 (n = 8), day 4 (n = 7) and day 10 (n = 8).
Prior to sacrifice, the 18-h urine was collected in metabolic cages for each group of animals. Urine volume and pH were readily determined by test strips. Urine was tested for the presence of protein, glucose, haemoglobin and ketone bodies, and centrifuged at 1500 min"' for 10 min in a Tehnica LC 320 laboratory centrifuge. Dialysis (PM exclusion 12000-14000), PolyLabo, Strasbourg, France) was performed against water for 3 h to remove possible enzyme inhibitors. Catalytic activities of the enzymes were then readily determined in the dialysed urine samples.
After sacrificing animals under ether narcosis on day 1, 4 and 10, blood was withdrawn from the umbilical vein. Blood serum was separated by centrifugation at 3000 min"· 1 for 10 min and serum urea concentration was determined.
Immediately after sacrifice, the kidneys were excised, washed in cold saline, dried with filter paper and freed from the connective tissue and capsules.
Renal cortex sections prepared with a microtome were minced, placed in 15ml buffer (Tris-HCl, 12 mmol/1, pH = 7.4; EGTA, 5 mmol/1; mannitol, 300 mmol/1), then homogenized with an Ultra Turrax homogenizer, type 18-10 (Janke & Kunkel, GK). Brush border membrane vesicles were isolated by precipitation with Mg ions, according to Biber et al. (14) , using a Beckman L5-65 ultracentrifuge. Protein concentration and catalytic activities of alanine aminopeptidase, alkaline phosphatase and γ-glutamyltransferase were determined in isolated brush-border membrane vesicles. Mean values of the factor of enzymatic activity enrichment, following brush border membrane vesicle isolation, were f = 11.0, f = 8.0 and f = 10.0 for alanine aminopeptidase, alkaline phosphatase and γ-glutamyltransferase, respectively.
Methods
The catalytic activity of alanine aminopeptidase was determined by the procedure of Haschen (15) 
Chemicals
Commercial test kits for alkaline phosphatase, γ-glutamyltransferase and urea were obtained from Herbos, Sisak, manufactured in cooperation with SKI (Smith & Kline Instruments, Inc. USA). EGTA, Fluka; HEPES and DL-alanine--naphthylamide · HC1, Sigma; and all other chemicals of analytical purity were obtained from Kemika, Zagreb.
The statistical significance of changes in enzyme catalytic activities in the experimental group samples, compared with those in control animals, were analysed by Student's t test for small samples (20) .
Results
Prior to the determination of enzyme catalytic activities in the samples, an in vitro experiment performed on pool serum showed that sodium valproate caused no significant interference in the determination of alanine aminopeptidase, alkaline phosphatase and γ-glutamyltransferase catalytic activities.
A routine urine analysis was performed to test kidney function. Protein, glucose, ketone bodies and haemoglobin appeared to be normal in all groups of animals. Moreover, the concentration of urea in serum as well as the concentration of protein in kidney brush border membrane vesicles did not change throughout the experiment.
After four days of sodium valproate administration, the 18-h urine volume was significantly increased (9.2 ± 4.2 ml) in comparison with the control group (3.06 ± 1.8 ml) (p < 0.05); urine pH was markedly increased to 10.5 after 10 days of sodium valproate administration (control group, pH = 6.0) (tab. 1).
Changes in the enzyme catalytic activities in 18-h urine samples and isolated renal brush-border membrane vesicles are shown in figures 1, 2 and 3. On day 1 of the administration of sodium valproate, only the catalytic activity of alanine aminopeptidase in urine was increased significantly (2.0 times that found in the control group; p < 0.05) ( fig. 1) . The enzyme activity gradually decreased, attaining control group values on day 10. In isolated renal brush-border membrane vesicles, the alanine aminopeptidase activity showed a significant change only on day 1 of the experiment.
The catalytic activities of γ-glutamyltransferase and alkaline phosphatase in the urine of experimental animals were significantly increased on day 4 of sodium valproate administration (γ-glutamyltransferase, 2.69-fold, p < 0.05; alkaline phosphatase, 3.02-fold, ρ < 0.001) ( figs. 2 and 3) . On day 10 of the treatment, the catalytic activity of γ-glutamyltransferase in urine was within the control group values, whereas the catalytic activity of alkaline phosphatase was below the control group value. The activity of y^glutamyltransferase in isolated renal brush-border membrane vesicles was,decreased about 0.30-, 0.40-and 0.18-fold on days 1, 4 and 10, respectively, whereas the activity of alkaline phosphatase was significantly increased (from 1.45-fold on days 1 and 4 to 2.18-fold on day 10 of the trial; p < 0.05).
Discussion
A relatively small number of adverse effects of sodium valproate on kidney cells have been reported in the literature (10, 11). On the other hand, numerous effects of the drug on kidney metabolism, such as increased metabolism of glutamine and increased synthesis of ammonium, significantly decreased renal absorption of lactate and pyruvate, inhibition of long-chain fatty acid oxidation, decreased synthesis of carnitine in the kidney, inhibition of ketogenesis, mitochondrial dysfunction, etc., have been reported (9, 21) . All these changes appear to support the hypothesis that treatment of epilepsy with sodium valproate might damage kidney cells, depending on the duration of therapy, dosage and individual susceptibility.
For the following, we focused our attention on the activity of enzymes localized on the renal proximal tubule cells: according to Warter et al. (8) , sodium valproate, a short-chain fatty acid, affects the structure of the cell membrane; by histologic examination of the renal tissue from patients with interstitial nephritis due to sodium valproate, China-Young Lin & Huang Ching (11) found dense material deposited in the basal membrane of tubular cells; considerable amounts of sodium valproate are metabolised in the cells of proximal and distal tubules of the kidney (22) .
The investigated enzymes are known as surface enzymes or integral constituents of the brush-border membrane cells of the kidney proximal tubules. Their urinary excretion is considered to be a useful early indicator of kidney alterations (13) .
The time-dependent and significantly elevated catalytic activities of the three enzymes in the urine of experimental animals pointed to an adverse action of the drug on the kidney cells. The catalytic activity of alanine aminopeptidase was significantly increased as early as Eur J Clin Chem CHn Biochem 1995; 33 (No 10) the first day after sodium valproate administration, which is consistent with the finding that the enzyme is readily released from the surface of the cell membrane (23) . A relatively early urinary excretion of alanine aminopeptidase was also observed by Holmes et al. (24) in their study of the coordinated release of urinary lysosomal and brush-border enzymes following renovascular surgery. The authors conclude that cell components, including enzymes, are affected by transitory pathophysiologic changes in the kidney. We postulate that the decreased enzyme activity in urine after 10 days of treatment was probably due to a significant change in urine pH. By urine dialysis, we eliminated the inhibitors of alanine aminopeptidase and other enzymes. However, it is known from the literature (25) that enzymatic activity can be decreased by prolonged urine retention in the bladder, as well as by urine collection over a prolonged period of time, as in our experiment (18 h). The use of sodium valproate is associated with an increased formation of ammonium ions in the body. Thus, the above data, and the fact that ammonium ions are known to inhibit alanine aminopeptidase ( (26), appears to invalidate this enzyme as a diagnostic indicator of adverse changes in kidney cells during the administration of this drug.
Although the incorporation of γ-glutamyltransferase into the cell membrane lipid matrix is, according to the literature, weaker than that of alkaline phosphatase (23), marked enzymuria, together with notable polyuria, was observed concurrently for both enzymes on day 4 to the drug administration. These results are consistent with the observations of Jung et al. (27) , who found that an increased water intake, i. e. increased diuresis in normal subjects, resulted in an increased excretion of soluble forms of the brush-border membrane enzymes, whereas the excretion of particulate forms was independent of diuresis. Therefore, in our future studies with sodium valproate, it might prove useful to determine both forms of γ-glutamyltransferase and alkaline phosphatase, or to express the enzyme catalytic activities in relation to creatinine concentration, which is one of the recommended ways of expressing urinary enzyme catalytic activities (25) . The observed normalization of urine enzyme activities after 10 days may reflect the adaptation of renal cells to the presence of the drug. These changes in the enzyme catalytic activities are consistent with data obtained in similar studies of renal cell impairment (28) . Most of these studies show an intermittent increase in urinary enzyme activities, depending on the study duration or the concentration of the potentially toxic substance.
Whereas the activity of γ-glutamyltransferase in isolated renal brush-border membrane vesicles decreased as expected, the marked increase in the activity of alkaline phosphatase was probably due to the enhanced synthesis of enzyme multiple forms in the renal tissue (intestinallike and hepatic types) and subsequent excretion in the urine. Thus, Pfleiderer et al. (29) found an increased amount of the intestinal-like forms of alkaline phosphatase in the urine from subjects receiving potentially toxic drugs.
In our experiments with rats, 200 mg/kg body weight sodium valproate per day appeared to cause transient changes in renal cell membranes, resulting, over a period of 10 days, in increased enzymuria of the specific enzymes, polyuria, and changes in urine pH. Proteinuria, microhaematuria and histological alterations due to the use of sodium valproate have also been demonstrated in humans (11) . Thus, the data presented appear to suggest that the state of renal cells should be monitored during therapy with sodium valproate. This is especially important if it is given over a long period, during which not only transitory but also more severe damage to the renal tubular cells can be expected to occur. As urinary enzymes are very early indicators of adverse renal cell changes, the present results indicate that the determination of urinary catalytic activities of γ-glutamyltransferase and alkaline phosphatase may be useful for monitoring patients for adverse effects of sodium valproate treatment.
